WiseGuyReports

Circulating Tumor Cell (CTC) Diagnostics Market 2017 Global Share, Trend, Segmentation and Forecast to 2021

The analysts forecast the global circulating tumor cell (CTC) diagnostics market to grow at a CAGR of 9.39% during the period 2017-2021.

 

New York, NY -- (SBWIRE) -- 11/14/2017 -- Global Circulating Tumor Cell (CTC) Diagnostics Market

Description

WiseGuyReports.Com adds" Global Circulating Tumor Cell (CTC) Diagnostics Market 2017-2021 "Research To Its Database.

Cancer is diagnosed by blood count, bone marrow biopsy, and molecular identification of mutated cells. CTC diagnostics helps in the identification of deoxyribonucleic acid (DNA) shed by tumor cells. CTCs are cancerous cells which detach from primary tumor and migrate in the bloodstream or lymphatic system of the patient. CTCs in the blood or lymphatic system helps in providing important information regarding prognosis and treatment effectiveness for cancer patients.

The analysts forecast the global circulating tumor cell (CTC) diagnostics market to grow at a CAGR of 9.39% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global circulating tumor cell (CTC) diagnostics market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

Get sample Report @  https://www.wiseguyreports.com/sample-request/2373859-global-circulating-tumor-cell-ctc-diagnostics-market-2017-2021

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The Global Circulating Tumor Cell (CTC) Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- ApoCell
- Qiagen
- Menarini Silicon Biosystems

Other prominent vendors
- Advanced Cell Diagnostics
- BioCep
- BIOCEPT
- BioFluidica
- Celltraffix
- Clearbridge Biomedics
- Creatv MicroTech
- Cynvenio
- Epic Sciences
- Fluxion Biosciences
- Gilupi
- Ikonisys
- IVDiagnostics
- ScreenCell

Market driver
- Increasing incidences of cancer
- For a full, detailed list, view our report

Market challenge
- High cost of diagnostics
- For a full, detailed list, view our report

Market trend
- Introduction of advanced detection technologies
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?

Report Details @ https://www.wiseguyreports.com/reports/2373859-global-circulating-tumor-cell-ctc-diagnostics-market-2017-2021

 

Table of Contents -Major Key Points

PART 01: Executive summary 

PART 02: Scope of the report 

PART 03: Research Methodology 

PART 04: Introduction
- Market outline

PART 05: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis

PART 06: Market segmentation by end-user
- Market overview

PART 07: Geographical segmentation
- Overview
- Americas
- EMEA
- APAC

PART 08: Decision framework 

PART 09: Drivers and challenges
- Market drivers
- Market challenges

PART 10: Market trends
- Introduction of advanced detection technologies
- Application of CTC as biomarkers for drug discovery

PART 11: Vendor landscape
- Competitive scenario

PART 12: Key vendor analysis
- ApoCell
- Menarini Silicon Biosystems
- Qiagen
- Other prominent vendors

………..CONTINUED